Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment
FRIDAY, Dec. 17, 2021 (HealthDay News) — A protocol could identify candidates who do not require formal in-person psychological assessment for workup of neuromodulation therapies for pain, according to a study presented at the 20th Annual Pain Medicine Meeting, a meeting of the American Society of Regional Anesthesia and Pain Medicine, held from Nov. 18 to 20 in San Francisco.
Fung Ping Wong, from Toronto Western Hospital, and colleagues compared the outcomes of neuromodulation trials and implants in patients who bypassed an in-person psychological assessment (fast-track cohort; 57 participants) versus those who had the assessment (114 participants). The fast-track protocol incorporates a short mental health checklist and predefined cutoffs for validated questionnaires, with patients screening positive for unresolved psychological conditions undergoing an in-person psychological assessment.
The researchers found that 72 percent of patients having the psychological assessment and 70 percent in the fast-track group had a successful spinal cord stimulation trial. At six to 12 months following the implant (78 patients with follow-up data), 48.15 percent of patients in the fast-track group and 47.06 percent of patients receiving the psychological assessment had ≥30 percent reduction in pain scores from preimplant levels.
“An algorithm incorporating predefined thresholds on validated questionnaires and a mental health checklist can be used to identify patients who do not need a formal in-person psychological assessment without a negative impact on outcomes of neuromodulation therapies for pain,” the authors write. “This can help reduce wait times and optimize utilization of health care resources.”
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions